LarsenSchultz FDiepgenTSvenssonA. The occurrence of atopic dermatitis in north Europe: An international questionnaire study. J Am Acad Dermatol1996; 34:760–764.
2.
AbsolonCMCottrellDEldridgeSMGloverMT. Psychological disturbance in atopic eczema: The extent of the problem in school-aged children. Br J Dermatol1997; 137: 241–245.
3.
WahlgrenCFHagermarkOBergstromR. The antipruritic effect of a sedative and a non-sedative antihistamine in atopic dermatitis. Br J Dermatol1990; 122:545–551.
4.
Berth-JonesJGraham-BrownRAC. Failure of terfenadine in relieving the pruritus of atopic dermatitis. Br J Dermatol1989; 121:635–637.
5.
SimonsFERSimonsKJBeckerABHaydeyRP. Pharmacokinetics and antipruritic effects of hydroxyzine in children with atopic dermatitis. J Pediatr1984; 104:123–127.
6.
HannukselaMKalimoKLammintaustaK. Dose ranging study: Cetirizine in the treatment of atopic dermatitis in adults. Ann Allergy Asthma Immunol1993; 70:127–133.
7.
FroschPJSchwanitzHJMacherE. A double blind trial of H1 and H2 receptor antagonists in the treatment of atopic dermatitis. Arch Dermatol Res1984; 276:36–40.
8.
YoshidaHNiimuraMUedaH. Clinical evaluation of ketotifen syrup on atopic dermatitis: A comparative multi-center double-blind study of ketotifen and clemastine. Ann Allergy Asthma Immunol1989; 62:507–512.
9.
MelnikBHollmannJPlewigG. Decreased stratum corneum ceramides in atopic individuals—a pathobiochemical factor in xerosis? (Letter). Br J Dermatol1988; 119:547–549.
10.
LuckyAWLeachADLaskarzewskiPWenckH. Use of an emollient as a steroid-sparing agent in the treatment of mild to moderate atopic dermatitis in children. Pediatr Dermatol1997; 14:321–324.
11.
AndersenPHBindslev-JensenCMosbechH. Skin symptoms in patients with atopic dermatitis using enzyme-containing detergents. A placebo-controlled study. Acta Derm Venereol1998; 78:60–62.
12.
JujoKRenzHAbeJ. Decreased interferon gamma and increased interleukin-4 production in atopic dermatitis promotes IgE synthesis. J Allergy Clin Immunol1992; 90:323–331.
13.
ReinholdUWehrmannWKukelSKreyselHW. Evidence that defective interferon-gamma production in atopic dermatitis patients is due to intrinsic abnormalities. Clin Exp Immunol1990; 79:374–379.
14.
SulzbergerMBWittenVH. The effect of topically applied compound F in selected dermatoses. J Invest Dermatol1952; 101–102.
15.
YamamotoK. How doctor's advice is followed by mothers of atopic children. Acta Derm Venereol Suppl (Stockh)1989; 144:31–33.
16.
AkersWA. Risks of unoccluded topical steroids in clinical trials. Arch Dermatol1980; 116:786–788.
17.
FeiwelMKellyWF. Adrenal unresponsiveness associated with clobetasol propionate (Letters to the Editor). Lancet1974; ii:112–113.
18.
MaibachHIWesterRC. Issues in measuring percutaneous absorption of topical steroids. Int J Dermatol1992; 31: 21–25.
19.
KozowerMVeatchLKaplanMM. Decreased clearance of prednisolone, a factor in the development of corticosteroid side effects. J Clin Endocrinol Metab1974; 38:407–412.
20.
AllenbyCFMainRAMarsdenRASparkesCG. Effect on adrenal function of topically applied clobetasol propionate (Dermovate). Br Med J1975; 4:619–621.
21.
JohnsAMBowerBD. Wasting of the napkin area after repeated use of fluorinated steroid ointment. Br Med J1970; 1:347–348.
22.
GriceK. Tinea of the hand and forearm Betamethasone valerate atrophy. Proc R Soc Med Nov 1965; 254–255.
23.
HoskingGPEllistonH. Benign intracranial hypertension in a child with eczema treated with topical steroids. Br Med J1978; 1:550–551.
24.
BensonPFPharoahPOD. Benign intracranial hypertension due to adrenal steroid therapy. Guy's Hospital Reports1960; 212–218.
25.
VermeerBJHeremansGFP. A case of growth retardation and Cushing's syndrome due to excessive application of Betamethasone-17-valerate ointment. Dermatologica1974; 149:299–304.
26.
Ruiz-MaldonadoRZapataGTamayoL. Cushing's syndrome after topical application of corticosteroids. Am J Dis Child1982; 136:274–275.
27.
DavidTJ. Short stature in children with atopic eczema. Acta Derm Venereol Suppl (Stockh)1989; 144:41–44.
28.
BrunstingLAReedWBBairHL. Occurrence of cataracts and keratoconus with atopic dermatitis. Arch Dermatol1955;72:237–241.
29.
FrancoHLWestonWL. Steroid rosacea in children. J Pediatr1979; 63:36–38.
30.
LutzMEel-AzharyRAGibsonLEFranswayAF. Contact hypersensitivity to tixocortol pivalate. J Am Acad Dermatol1998;38:691–695.
31.
StoresGBurrowsACrawfordC. Physiological sleep disturbance in children with atopic dermatitis: A case control study. Pediatr Dermatol1998; 15:264–268.
32.
GruleeCGSanfordHN. The influence of breast and artificial feeding on infantile eczema. J Pediatr1936; 9:223–225.
33.
SigursNHattevigGKjellmanB. Maternal avoidance of eggs, cow's milk, and fish during lactation: Effect on allergic manifestations, skin-prick tests, and specific IgE antibodies in children at age 4 years. Pediatrics1992; 89:735–739.
34.
ZeigerRSHellerSMellonMH. Genetic and environmental factors affecting the development of atopy through age 4 in children of atopic parents: A prospective randomized study of food allergen avoidance. Pediatr Allergy Immunol1992;3:110–127.
35.
KramerMSMorozB. Do breast-feeding and delayed introduction of solid foods protect against subsequent atopic eczema?J Pediatr1981; 98:546–550.
36.
MidwinterREMorrisAFColleyJRT. Infant feeding and atopy. Arch Dis Child1987; 62:965–967.
37.
AthertonDJSewellMSoothillJFWellsRS. Double-blind controlled crossover trial of an antigen-avoidance diet in atopic eczema. Lancet1978; i:401–403.
38.
SampsonHAAlbergoR. Comparison of results of skin tests, RAST, and double-blind, placebo-controlled food challenges in children with atopic dermatitis. J Allergy Clin Immunol1984; 74:26–33.
39.
DavidTJ. Dietary treatment of atopic eczema. Arch Dis Child1989; 64:1506–1509.
40.
TurnerMWBrostoffJMowbrayJF. The atopic syndrome: In vitro immunological characteristics of clinically defined subgroups of atopic subjects. Clin Allergy1980; 10:575–584.
41.
ChapmanMDRowntreeSMitchellEB. Quantitative assessment of IgE and IgG to inhalent allergens in patients with atopic dermatitis. J Allergy Clin Immunol1983; 72:27–33.
42.
WalshawMJEvansCC. Allergen avoidance in house dust mite sensitive adult asthma. Q J Med1986; 58:199–215.
43.
KorsgaardJ. Preventative measures in house-dust allergy. Am Rev Respir Dis1982; 125:80–84.
44.
GloverMTAthertonDJ. A double-blind controlled trial of hyposensitization to Dermatophagoides pteronyssi'nus in children with atopic eczema. Clin Exp Allergy1992; 22: 440–446.
45.
KiefferMBergbrantIMFaergemannJ. Immune reactions to Pityrosporum ovale in adult patients with atopic and seborrheic dermatitis. J Am Acad Dermatol1990; 22: 739–742.
46.
RokugoMTagamiHUsubaYTomitaY. Contact sensitivity to Pityrosporum ovale in patients with atopic dermatitis. Arch Dermatol1990; 126:627–632.
LeungDYMHarbeckRBinaP. Presence of IgE antibodies to staphylococcal exotoxins on the skin of patients with atopic dermatitis. J Clin Invest1993; 92:1374–1380.
49.
LeverRHadleyKDowneyDMackieR. Staphylococcal colonization in atopic dermatitis and the effect of topical mupirocin therapy. Br J Dermatol1988; 119:189–198.
50.
FalkES. U-V light therapies in atopic dermatitis. Photo Dermatol1985; 2:241–246.
51.
JeklerJLarkoO. Combined UVA-UVB versus UVB phototherapy for atopic dermatitis: A paired-comparison study. J Am Acad Dermatol1990; 22:49–53.
52.
KrutmannJSchopfE. High-dose-UVA1 phototherapy: A novel and highly effective approach for the treatment of acute exacerbation of atopic dermatitis (Review). Acta Derm Venereol Suppl (Stockh)1992; 176:120–122.
53.
JeklerJLarkoO. UVA solarium versus UVB phototherapy of atopic dermatitis: A paired-comparison study. Br J Dermatol1991; 125:569–572.
54.
KrutmannJCzechWDiepgenT. High-dose-UVA1 therapy in the treatment of patients with atopic dermatitis. J Am Acad Dermatol1992; 26:225–230.
55.
AthertonDJCarabottFGloverMTHawkJLM. The role of psoralen chemotherapy (PUVA) in the treatment of severe atopic eczema in adolescence. Br J Dermatol1988; 118: 791–795.
56.
YoshimuraMNamuraSAkamatsuHHorioT. Antimicrobial effects of phototherapy and photochemotherapy in vivo and in vitro. Br J Dermatol1996; 135:528–532.
57.
KaplanRJDamanLRosenbergEWFeigenbaumS. Topical use of caffeine with hydrocortisone in the treatment of atopic dermatitis. Arch Dermatol1978; 114:60–62.
58.
RasmussenJE. Advances in nondietary management of children with atopic dermatitis (Review). Pediatr Dermatol1989; 6:210–215.
59.
Berth-JonesJGraham-BrownRA. Failure of papaverine to reduce pruritus in atopic eczema: A double-blind, placebo-controlled cross-over study. Br J Dermatol1990; 122:553–557.
60.
HaiderSA. Treatment of atopic eczema in children: Clinical trial of 10 percent sodium cromoglycate ointment. Br Med J1977; 1:1570–1572.
61.
MolkhouPWaguetJ-C. Food allergy and atopic dermatitis in children: Treatment with oral sodium cromoglycate. Ann Allergy1981;47:173–175.
62.
KimataHIgarashiM. Topical cromolyn (disodium cromoglycate) solution in the treatment of young children with atopic dermatitis. Clin Exp Allergy1990; 20:281–283.
63.
ThirumoorthyTGreavesMW. Disodium cromoglycate ointment in atopic eczema. Br Med J1978; 2:500–501.
64.
KjellmanNIGustafssonIM. Topical sodium cromoglycate in atopic dermatitis. Allergy1986; 41:423–428.
65.
MorrisonJGLSchulzEJ. Treatment of eczema with cyclophosphamide and azathioprine. Br J Dermatol1978; 98:203–207.
GuentherLWexlerD. Efamol and the treatment of atopic dermatitis (Letter). J Am Acad Dermatol1987; 17:860.
68.
SheehanMPAthertonDJ. A controlled trial of traditional Chinese medicinal plants in widespread non-exudative atopic eczema. Br J Dermatol1992; 126:179–184.
69.
SheehanMPRustinMHAAthertonDJ. Efficacy of traditional Chinese herbal therapy in adult atopic dermatitis. (published erratum appears in Lancet 1992; 340:188) Comment in: Lancet1992; 340: 673–674, and Lancet1993; 342:1175–1176.
70.
DaviesEGPollockISteepHM. Chinese herbs for eczema (Letter). Lancet1990; 336:177.
71.
Graham-BrownR. Toxicity of Chinese herbal remedies (Letter). Lancet1992; 340:673.
72.
FergusonJEChalmersRJGRowlandsDJ. Reversible dilated cardiomyopathy following treatment of atopic eczema with Chinese herbal medicine. Br J Dermatol1997; 136:592–593.
73.
Di Prisco de FuenmayorMCChampionRH. Specific hyposensitization in atopic dermatitis. Br J Dermatol1979; 101:697–700.
74.
McMenamyCJKatzRGGipsonM. Treatment of eczema by EMG biofeedback and relaxation training: A multiple baseline analysis. J Behav Ther Exp Psychiatry1988; 19:221–227.
75.
KoehlerTWeberD. Psychophysiological reactions of patients with atopic dermatitis. J Psychosom Res1992; 36:391–394.
